Summary
Signal counts
Assets tracked: 3
Watchlist assets: 3
Registry stop assets: 0
Sponsor overview
National University Hospital, Singapore
Public clinical-program risk signals across linked oncology Phase 2 assets for this sponsor.
Evidence links
Public sources
https://clinicaltrials.gov/study/NCT02811354 | https://clinicaltrials.gov/study/NCT05719428 | https://clinicaltrials.gov/study/NCT01739894
Assets
Linked programs
- AZD9291: Timeline Staleness Signal (4/5)
- DRUID AI Program: Watchlist Signal (2/5)
- IP Paclitaxel: Timeline Staleness Signal (3/5)